What & Who We Fund

-

Research Focus

Comparative Clinical Effectiveness Research (CER)

Studies that compare outcomes to determine the effectiveness, including risks and benefits, of two or more approaches to health care

Targeted PCORI Funding Announcements

Open Tuesday, September 7, 2021

PCORI 2021 and Beyond: Opportunities for Funding and Involvement in Patient-Centered Research: Watch the webinar Executive Director Nakela L. Cook, MD, MPH, and other PCORI leaders shared our bold vision for 2021, including new and improved funding appro

CER Methods and Infrastructure

Studies to improve the methods available for patient-centered CER  

Development of a large, highly representative electronic-data infrastructure called PCORnet®, The National Patient-Centered Clinical Research Network, for improving the conduct of patient-centered CER

Conditions Studied

We pay particular attention to:

  • Conditions that affect large numbers of people across a range of populations
  • Conditions that place a heavy burden on individuals, families, specific populations, and society
  • Rare diseases, which are difficult to study

Populations of Interest

We pay particular attention to a number of populations in making research funding decisions:

  • Racial and ethnic minorities
  • Older adults
  • Low-income
  • Residents of rural areas
  • Women
  • Children
  • Individuals with special healthcare needs, including individuals with disabilities, individuals with multiple chronic diseases, individuals with rare diseases, and individuals whose genetic makeup affects their medical outcomes
  • Patients with low health literacy/numeracy and limited English proficiency
  • Lesbian, gay, bisexual, transgender and queer (LGBTQ+) populations/persons
  • Veterans and members of the armed forces and their families

Eligibility

Private Sector

  • Nonprofit research organizations
  • For-profit research organizations

Public Sector

  • Universities and colleges
  • Hospitals and healthcare systems
  • Laboratories and manufacturers
  • Units of state, local, or federal government

US Organizations

Must be recognized by the Internal Revenue Service

Foreign Organizations and Nondomestic Components of US Organizations

May apply if:

  • There is demonstrable benefit to the US healthcare system, and the essential scientific needs will be met by conducting the study outside the United States or having the study conducted by non-US research organizations
  • US efforts in the area of patient-centered research can be clearly shown, and the engagement plans include US patients and stakeholders, and are relevant to US healthcare system

Individuals

Not permitted to apply

Posted: September 2014; Updated: April 2021